Pediatric Down Syndrome Post-Approval Study
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Inspire Medical Systems, Inc.
- Study ID
- NCT06851338
- Status
- Recruiting
Conditions
- Down Syndrome (DS)
- Pediatric Obstructive Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hypoglossal Nerve Stimulation — DEVICEImplant of Inspire Upper Airway Stimulation (UAS) system for treatment of obstructive sleep apnea (OSA) in the pediatric down syndrome population
Study Details
The purpose of this Post Approval research study is to assess ongoing safety and effectiveness of the Inspire therapy in adolescents and young adults (age 13-18) with Down syndrome and severe sleep apnea. The objective of the study is to provide an ongoing safety and effectiveness assessment of the Inspire UAS System in the Pediatric Down syndrome population.
Key Dates
- Start date
- Feb 28, 2025
- Status verified
- Feb 2025
- Primary completion
- May 31, 2030
- Completion
- May 31, 2030
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Pediatric subjects with Down syndrome undergoing Inspire UAS ImplantThis study is a prospective, multi-center, single-arm study of pediatric subjects (age 13-18) with Down syndrome who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) system for the treatment of severe obstructive sleep apnea (OSA).
Primary Outcome Measure
Safety Outcome Measure - Procedure and Device-related Adverse events [ Time Frame: Implant through 5 Years ]
Central Contacts
- Angela Chapin, Sr. Clinical Study Manager763.392.7222
- Gwen Gimmestad, VP Clinical763.392.9966
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | Chase Beckerman Richard Law, MD |
| Children's Hospital Orange County | Orange | California | 92868 | Eric Rodriguez Chana Chin, MD |
| University of South Florida Morsani College of Medicine | Tampa | Florida | 33602 | Alex Czachor Abhay Sharma, MD |
| Northwell Cohen Children's Hospital | Queens | New York | 11040 | Virginia Mullooly Patrick Scheffler, MD |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | Alex Piczer Vaishal Shah, MD |
| Baylor College of Medicine/ Texas Children's Hospital | Houston | Texas | 77030 | Sadaf Batla Mary F Musso, MD |
Find similar trials in Phoenix, AZ
By research site
Phoenix Children's Hospital· Phoenix, AZChildren's Hospital Orange County· Orange, CAUniversity of South Florida Morsani College of Medicine· Tampa, FLNorthwell Cohen Children's Hospital· Queens, NYCleveland Clinic Foundation· Cleveland, OHBaylor College of Medicine/ Texas Children's Hospital· Houston, TX
Related Studies
- Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep ApneaRecruiting · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Bethesda, Maryland
- Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down SyndromePHASE3 · Recruiting · Woolfson Eye Institute · Atlanta, Georgia
- NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down SyndromePHASE1 · Not Yet Recruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Adapting RDAD for DSRecruiting · University of Kansas Medical Center · Kansas City, Kansas